Testing of biodegradable materials in the form of thin films in vivo (Q11934)

From EU Knowledge Graph
Revision as of 07:56, 2 December 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in de: translated_label)
Jump to navigation Jump to search
Project Q11934 in Czech Republic
Language Label Description Also known as
English
Testing of biodegradable materials in the form of thin films in vivo
Project Q11934 in Czech Republic

    Statements

    0 references
    248,040.0 Czech koruna
    0 references
    9,921.6 Euro
    10 January 2020
    0 references
    330,720.0 Czech koruna
    0 references
    13,228.80 Euro
    10 January 2020
    0 references
    75 percent
    0 references
    1 May 2018
    0 references
    31 October 2018
    0 references
    31 October 2018
    0 references
    Contipro a.s.
    0 references
    0 references

    49°59'36.92"N, 16°29'45.42"E
    0 references
    56102
    0 references
    Projekt je zaměřen na řešení problematiky biokompatibility, biodegradace a fyzikálních změn unikátních materiálů - tenkých filmů na bázi modifikovaného hyaluronanu v savčím organismu. Budou sledovány vlastnosti těchto filmů po jejich implantaci a budou stanovovány parametry jejich biokompatibility a degradace definovaných na základě požadovaných vlastností zdravotních prostředků pro jejich uplatnění v chirurgii. a. (Czech)
    0 references
    The project is focused on solving the problems of biocompatibility, biodegradation and physical changes of unique materials – thin films based on modified hyaluronan in mammalian organism. The properties of these films after implantation will be monitored and the parameters of their biocompatibility and degradation defined on the basis of the required properties of medical devices for their application in surgery will be determined. a. (English)
    22 October 2020
    0 references
    Le projet vise à résoudre les problèmes de biocompatibilité, de biodégradation et de changements physiques de matériaux uniques — films minces basés sur l’hyaluronane modifié dans l’organisme mammifère. Les caractéristiques de ces films seront surveillées après l’implantation et les paramètres de leur biocompatibilité et de leur dégradation définis sur la base des propriétés requises des dispositifs médicaux pour leur application en chirurgie doivent être déterminés. (French)
    28 November 2021
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/17_115/0012572
    0 references